C07D 239/90
With acyclic radicals attached in position 2 or 3
Official title: with acyclic radicals attached in position 2 or 3
C07D239/90 (With acyclic radicals attached in position 2 or 3) appears on 233 US grants and 229 published applications in this corpus.
Search patents in C07D- Granted patents
- 233
- Published applications
- 229
- Assignees
- 171
- Inventors
- 939
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 3 | 0 |
| 1979 | 3 | 0 |
| 1980 | 5 | 0 |
| 1981 | 5 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 4 | 0 |
| 1992 | 3 | 0 |
| 1993 | 3 | 0 |
| 1994 | 6 | 0 |
| 1995 | 8 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 10 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 1 |
| 2002 | 4 | 3 |
| 2003 | 5 | 6 |
| 2004 | 3 | 19 |
| 2005 | 1 | 16 |
| 2006 | 10 | 13 |
| 2007 | 10 | 9 |
| 2008 | 5 | 12 |
| 2009 | 8 | 16 |
| 2010 | 8 | 15 |
| 2011 | 10 | 10 |
| 2012 | 11 | 11 |
| 2013 | 12 | 8 |
| 2014 | 10 | 15 |
| 2015 | 12 | 13 |
| 2016 | 9 | 10 |
| 2017 | 8 | 3 |
| 2018 | 4 | 6 |
| 2019 | 3 | 3 |
| 2020 | 5 | 6 |
| 2021 | 2 | 5 |
| 2022 | 3 | 9 |
| 2023 | 1 | 7 |
| 2024 | 3 | 4 |
| 2025 | 3 | 6 |
| 2026 | 3 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Crystalline form, and process for its production11 Aug 2026US 12,703,688 B1Alterity Therapeutics Limited
- Compound for preventing or treating lipid metabolism-related diseases24 Mar 2026US 12,582,720 B2Fudan University
- Quinazolinone derivatives10 Mar 2026US 12,570,615 B2Hoffmann-La Roche Inc.
- PARP inhibitors for treating cancer and asthma2 Sep 2025US 12,404,250 B2Oregon Health & Science University
- Compounds for the treatment of BRAF-associated diseases and disorders20 May 2025US 12,303,509 B2Pfizer Inc.
- Benzopyrimidin-4(3h)-ones as pi3k inhibitors20 Aug 2026US 2026/0242398 A1OnKure, Inc.
- Hsd17b13 inhibitors and uses thereof9 Jul 2026US 2026/0193218 A1Inipharm, Inc.
- Pi3k inhibitor, preparation method therefor, and use thereof15 Jan 2026US 2026/0015341 A1Hinova Pharmaceuticals Inc.
- Photocatalysts, preparation and use thereof4 Dec 2025US 2025/0367649 A1The Royal Institution for the Advancement of Learning/Mcgill University
- Process for the preparation of a quinazolinone derivative9 Oct 2025US 2025/0313551 A1Hoffmann-La Roche Inc.
Most cited
By later US patents
- Modulators of ATP-binding cassette transporters109US 8,642,609 B2Vertex Pharmaceuticals Incorporated · 2014
- Synthesis of quinazolinone libraries and derivatives thereof104US 5,783,577 ATrega Biosciences, Inc. · 1998
- Piperidinylalkyl quinazoline compounds, composition and method of use85US 4,335,127 AJanssen Pharmaceutica NV · 1982
- Methods and compositions utilizing quinazolinones75US 6,545,004 B1Cytokinetics, Inc. · 2003
- Anti-tumour agents70US 4,992,550 AImperial Chemical Industries PLC · 1991